News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Citi: GALAXY ENT (00027.HK) 1Q Results Beat
Citi’s research report wrote that GALAXY ENT (00027.HK) delivered a 6% YoY hike in 1Q25 net revenue to HKD11.2 billion, with adjusted EBITDA rising 16% YoY to nearly HKD3.3 b...
Reset
Send
The window will close in 5 seconds
<Research>Citi: GALAXY ENT (00027.HK) 1Q Results Beat
Close
Recommend
7
Positive
21
Negative
5
 
SHORT SELL
 
STOCK INFO

Citi’s research report wrote that GALAXY ENT (00027.HK)  +0.300 (+0.987%)    Short selling $102.07M; Ratio 23.221%   delivered a 6% YoY hike in 1Q25 net revenue to HKD11.2 billion, with adjusted EBITDA rising 16% YoY to nearly HKD3.3 billion, surpassing Citi and market expectations by approximately 4%, likely driven by luck factors in the VIP segment.

Citi estimated GALAXY ENT's 1Q25 market share at about 19.5%, down 0.3 ppts QoQ. Citi gave a Buy rating on GALAXY ENT with a target price of HKD46.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-09 16:25.)

Related NewsG Sachs Cuts GALAXY ENT (00027.HK) TP to $47.6, Reiterates Rating at Buy

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.